Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2023-12-12 AGM Information
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
关于召开 2023 年第二次临时股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a detailed notice for the 2023 second extraordinary general meeting of shareholders of Guangdong Yongshun Biopharmaceutical Co., Ltd. It includes information about the meeting date, voting methods (onsite and online), agenda items such as board and supervisory committee elections, amendments to company bylaws, and governance matters. It does not contain financial statements or results but rather focuses on the meeting logistics and agenda. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document is not a report itself but a meeting notice and agenda, not a report publication announcement since it is substantive and detailed about the meeting. Therefore, the correct classification is AGM-R with high confidence.
2023-12-12 Chinese
募集资金管理制度
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of the company's internal governance policy specifically regarding the management of raised funds (募集资金管理制度). It includes the approval process by the board, detailed rules on the use, storage, and supervision of raised funds, and disclosure requirements. It is not a financial report, earnings release, or audit report. It is a regulatory announcement about governance and compliance related to capital management. The document is over 5,000 characters and contains substantive content, not just a brief notice or certification. It fits best under Capital/Financing Update (CAP) because it relates to the management and use of capital raised by the company, including regulatory compliance and internal controls on fundraising proceeds.
2023-12-12 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Guangdong Winsun Bio-Pharmaceutical Co., Ltd. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, and governance rules. It references relevant laws and regulations such as the Company Law of China, Securities Law, and Beijing Stock Exchange listing rules. The content is a comprehensive governance document outlining internal rules and procedures for the company and its shareholders. It is not a financial report, earnings release, or announcement. It is not a proxy statement or voting results announcement. It is a governance document detailing the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full document, not just an announcement or summary.
2023-12-12 Chinese
关于预计 2024 年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2024. It includes detailed descriptions of the nature, amounts, and counterparties of these transactions, as well as approvals from the board and supervisory committee, and independent directors' opinions. The document is not a full financial report but a regulatory disclosure about anticipated related party dealings, which is typical for regulatory filings. It does not contain comprehensive financial statements or detailed financial analysis that would classify it as an Annual Report (10-K) or Interim Report (IR). It also does not fit into categories like Capital/Financing Update or Earnings Release. The document is more detailed than a simple announcement but is primarily a regulatory disclosure about related party transactions and approvals. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-12-12 Chinese
董事会议事规则
Governance Information Classification · 95% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors'. It details the internal governance rules, procedures for board meetings, powers and responsibilities of the board, voting procedures, and other governance-related matters. It is issued by the company's board and dated December 13, 2023. There is no financial data, no audit information, no earnings or capital updates, no voting results, no legal proceedings, no merger or acquisition details, and no presentation or report publication announcement. The content is focused on governance structure and internal rules for board operations. Therefore, this document fits the category of Governance Information (CGR). The document length is 8494 characters, which is substantive and contains detailed governance rules, not a brief announcement or certification. Hence, the classification is CGR with high confidence.
2023-12-12 Chinese
关于拟修订《公司章程》公告
Governance Information Classification · 95% confidence The document is an announcement regarding proposed amendments to the company's Articles of Association (公司章程). It details specific changes to governance-related provisions, including the roles and responsibilities of independent directors, audit committees, board composition, and decision-making authorities. The document references relevant regulatory frameworks such as the Company Law, CSRC regulations, and Beijing Stock Exchange rules. It is issued by the company's board and is intended for shareholder approval at a general meeting. The content focuses on governance structure and internal rules rather than financial results or operational data. The document length is 7044 characters, which is substantive and contains detailed governance information rather than a brief announcement or a report publication notice. Therefore, the most appropriate classification is Governance Information (CGR).
2023-12-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.